Free Trial

La Jolla Pharmaceutical (LJPC) ESG Score & Sustainability Data

→ He Is Giving Away Bitcoin (From Crypto Swap Profits) (Ad)
Free LJPC Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Sustainability
Stock Analysis

Key ESG Takeaways for La Jolla Pharmaceutical

The key takeaways are AI-generated and highlight the main contributors behind the net impact scores of La Jolla Pharmaceutical. The insights are based on millions of scientific articles, along with the company-specific product and service portfolio.
  • La Jolla Pharmaceutical seems to create the most significant positive value in categories , , and . The largest positive contribution comes from its impact, which is false driven by its Angiotensin II receptor blockers and Tetracyclines products.
  • On the other hand, these positive outcomes are achieved by using resources or causing negative impacts in categories , , and . The largest negative impact of La Jolla Pharmaceutical in category is driven by its Tetracyclines and Angiotensin II receptor blockers products.
  • To improve its net impact, a company can either grow its positive impacts, or reduce its negative impacts. For example, by doubling its Angiotensin II receptor blockers business, La Jolla Pharmaceutical would improve its net impact ratio by 14 percentage points.

LJPC Impact Ratio

Net impact ratio represents the net impact of a company. It is defined as the (positive impacts - negative impacts) / positive impacts. The maximum value for net impact ratio is 100%, representing a theoretical company with no negative impacts. The minimum value is -∞. Net scores depend on the value sets that determine the importance of different impact categories.
+13.9%
The default value set, where each category is given the same weight.

Value Sets Value sets can be used to assess how different stakeholder values or emphasis on certain values might affect the net impact ratio.

Millennials
Value set of millennials (b. 1980 - 1999), based on Upright's annual Impact at Work survey.
+29.4%
Most Wanted Workforce
Value set of the most wanted workforce, based on Upright's annual Impact at Work survey.
-23.2%
Society First
Value set that emphasizes society impacts over other impacts.
-169.2%
Knowledge First
Value set that emphasizes knowledge impacts over other impacts.
+4.0%
Health First
Value set that emphasizes health impacts over other impacts.
+36.8%

La Jolla Pharmaceutical ESG Score + Net Impact Profile

ImpactNegativeScorePositive
+0.60
+0.60
+1.21
+1.21
+0.33
+0.33
-0.02
+0.07
+0.09
-0.14
-0.12
+0.03
+0.00
+0.00
+0.03
+0.03
-0.00
+0.00
+0.00
-1.42
-1.42
-4.08
+2.50
+6.58
-0.02
+0.44
+0.47
0.00
+0.00
-0.00
+0.00
+0.00
-0.00
+0.52
+0.52
-1.02
-0.99
+0.03
-0.60
-0.59
+0.01
-0.11
-0.11
+0.00
-0.31
-0.31
+0.00
-0.83
-0.78
+0.05

Upright Model Version 0.4.0
ESG Data Last Updated: April 1, 2022

Ad Prosper Trading Academy
These AI trades triggered this morning (545% return)
If you think a market crash is possible in 2024, I don't know why you're not using this yet.
Click Here To Get Your Free Copy

About Upright's Net Impact Model

Upright Model

Upright's Net Impact Data quantifies the holistic value creation and impact of companies. It details both the negative and positive impacts a company has on the environment, health of people, society and knowledge, and forms a net sum of these costs and gains based on the economic costs of each impact category. The data is produced by Upright's Net Impact model, which is a mathematical model of the economy that produces continuously updated estimates of the net impact of companies by means of an information integration algorithm. The data is primarily sourced from the CORE open access database, which contains over 200 million scientific papers. Other sources of data include open databases published by the World Bank, IMF, WHO, OECD, IPCC, CDC and USDA.

La Jolla Pharmaceutical ESG Score - Frequently Asked Questions

How is La Jolla Pharmaceutical doing in terms of sustainability?

According to The Upright Project, which measures holistic value creation and impact of companies, La Jolla Pharmaceutical has a net impact ratio of 13.9%, indicating an overall positive sustainability impact. La Jolla Pharmaceutical seems to create the most significant positive value in the categories of Physical diseases, Taxes, and Jobs. On the other hand, these positive outcomes are achieved by using resources or causing negative impacts in the categories of Physical diseases, Scarce human capital, and GHG emissions. Learn more on the sustainability of La Jolla Pharmaceutical.


More ESG Stocks and Research Tools

Related Companies:
Stock Lists:
Sustainability Tools:
This page (NASDAQ:LJPC) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners
These AI trades triggered this morning (545% return)
Prosper Trading Academy
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
He Is Giving Away Bitcoin
Crypto Swap Profits
Jim Cramer’s “The Biggest Drug Ever”
Behind the Markets
Your Money is Not Safe
American Alternative
The AI stock to buy right now
StockEarnings
The only accurate crypto trading system I know …
Weiss Ratings